Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
309M
-
Number of holders
-
277
-
Total 13F shares, excl. options
-
312M
-
Shares change
-
-7.72M
-
Total reported value, excl. options
-
$2.46B
-
Value change
-
-$41.7M
-
Put/Call ratio
-
0.96
-
Number of buys
-
150
-
Number of sells
-
-124
-
Price
-
$7.88
Significant Holders of AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) as of Q3 2025
333 filings reported holding FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share as of Q3 2025.
AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) has 277 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 312M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (29.5M shares), WELLINGTON MANAGEMENT GROUP LLP (28.6M shares), BlackRock, Inc. (25.8M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (15.7M shares), Avoro Capital Advisors LLC (15M shares), MILLENNIUM MANAGEMENT LLC (11.8M shares), STATE STREET CORP (11.6M shares), Vestal Point Capital, LP (9.75M shares), CITADEL ADVISORS LLC (8.25M shares), and Point72 Asset Management, L.P. (7.16M shares).
This table shows the top 277 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.